Farmak JSC has developed and launched into the market the arterial hypertension drug for the patients whom the combined therapy is advised. A new product is called Ramizes® Com. The drug is produced in tablets.
Ramizes® Com is a combined Ramipril-and-Hydrochlorothriazide preparation. Classical combination of these active pharmaceutical ingredients is acknowledged by the specialists all over the world as one of the most optimal arterial hypertension medication.
Ramizes® Com is produced in two dosages: 2,5mg Ramipril /12,5 mg Hydrochlorothriazide (30 tablets in a package), or 5 mg Ramipril /25 mg Hydrochlorothriazide (30 tablets in a package).
Maria Savelieva, Marketing Specialist of Farmak’s Cardiological and Neurological Drugs Department: “Ramizes® Com has some benefits. Especially, it is easy-to-use – just to take 1 tablet a day. Total anti-hypertension effect potential of the preparation ingredients allows considerably increase the number of patients with stable arterial blood pressure reduction. The ability to reduce dosage-dependent side effects owing to the dosage reduction of the combined preparations as well by reciprocal effects neutralization. Decrease of the treatment expenses through the price for the combined preparations included in Ramizes® Com that is lower than the price for their ingredients taken separately. Ramizes® Com is the most effective organs protection and reduction of cardiovascular complications risk.’
Volodymyr Kostiuk, Executive Director of “Farmak”, has ranked the best top managers in his field of work. Volodymyr Kostiuk has been employed by “Farmak” since 2008 and appointed as the Executive Director in 2012. The strategic task of Volodymyr Kostiuk is to strengthen the positions of JSC “Farmak” in the international markets, expand the geography [&helli...
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]